Elos Medtech - Year-end report, 1 January – 31 December 2015
• Net sales amounted to SEK 503.7 M (380.9), up 26.4%, of which organic growth accounted for minus 1.1%*. The unit in Tianjin had a negative impact on growth and the remaining units contributed with a positive growth of 4.9%*. • Order bookings were SEK 472.6 M (418.1), up 8.0%*. Onyx Medical continued to contribute positively to order bookings. The lower demand in Tianjin had a negative impact on the year, this unit’s current workload indicates a return to normal levels. • Operating profit,prior non-recurring items, totalled SEK 38.7 M (36.5). The strong trend for Onyx Medical